Uncategorized
AqueSys completes enrollment for clinical trial of Xen 45 gel stent
AqueSys has completed enrollment in a U.S. investigational study of the Xen 45 gel stent, according to a press release.The stent is designed to achieve IOP reduction through a minimally invasive technique using a disposable injector with a 27-gauge needle pre-loaded with the device.